» Articles » PMID: 33580036

Association Between Chronic Obstructive Pulmonary Disease and Ventricular Arrhythmia: a Nationwide Population-based Cohort Study

Overview
Date 2021 Feb 13
PMID 33580036
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The ventricular arrhythmia (VA)-chronic obstructive pulmonary disease (COPD) association and related risk factors remain unclear. Using 2001-2012 data from National Health Insurance Research Database, we retrospectively reviewed 71,838 patients diagnosed as having COPD and 71,838 age- and sex-matched controls. After adjustments for comorbidities, medication, urbanization level, and monthly income, patients with COPD had higher incidence rates of VA than did the controls (adjusted hazard ratio [aHR] [95% confidence interval (CI)]: 1.45 [1.25-1.68]). More hospitalization or emergency visits because of acute COPD exacerbation (aHRs [95% CIs] for first, second, and third visits: 1.28 [1.08-1.50], 1.75 [1.32-2.32], and 1.88 [1.46-2.41], respectively) and asthma-COPD overlap (aHR [95% CI]: 1.49 [1.25-1.79]) were associated with high VA risk in patients with COPD. In the multivariate analysis, heart failure (aHR [95% CI]: 2.37 [1.79-3.14]), diabetes (aHR [95% CI]:1.64 [1.29-2.08]), age ≥75 (aHR [95% CI]: 2.48 [1.68-3.67]), male (aHR [95% CI]: 1.69[1.34-2.12]), and class III antiarrhythmic drug use (aHR [95% CI]: 2.49 [1.88-3.28]) are the most significant risk factors of new onset of VA in patients with COPD.

Citing Articles

Features of Atrial Fibrillation Pathogenesis and Prognosis in Chronic Obstructive Pulmonary Patients during the COVID-19 Pandemic.

Hazarapetyan L, Zelveian P, Grigoryan S Rev Cardiovasc Med. 2024; 24(2):51.

PMID: 39077394 PMC: 11273105. DOI: 10.31083/j.rcm2402051.


Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review.

Singh D, Han M, Hawkins N, Hurst J, Kocks J, Skolnik N Adv Ther. 2024; 41(6):2151-2167.

PMID: 38664329 PMC: 11133105. DOI: 10.1007/s12325-024-02855-4.


EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.

Nordon C, Rhodes K, Quint J, Vogelmeier C, Simons S, Hawkins N BMJ Open. 2023; 13(4):e070022.

PMID: 37185641 PMC: 10151875. DOI: 10.1136/bmjopen-2022-070022.


Association of Chronic Obstructive Pulmonary Disease With Arrhythmia Risks: A Systematic Review and Meta-Analysis.

Liu X, Chen Z, Li S, Xu S Front Cardiovasc Med. 2021; 8:732349.

PMID: 34660734 PMC: 8514787. DOI: 10.3389/fcvm.2021.732349.

References
1.
Shantakumar S, Pwu R, Dsilva L, Wurst K, Kuo Y, Yang Y . Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study. BMC Pulm Med. 2018; 18(1):16. PMC: 5784537. DOI: 10.1186/s12890-017-0571-7. View

2.
Groenewegen K, Schols A, Wouters E . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003; 124(2):459-67. DOI: 10.1378/chest.124.2.459. View

3.
Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli B . Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J. 2008; 32(5):1275-82. DOI: 10.1183/09031936.00151707. View

4.
Yeh J, Wei Y, Lin C, Hsu W . Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study. BMJ Open. 2017; 7(10):e017657. PMC: 5640024. DOI: 10.1136/bmjopen-2017-017657. View

5.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View